Valuation check: IMRNW's PEG ratio is -5.29, below the Healthcare sector average of 2.56.
Get informed when a big investor buys or sells
+ Follow-5.29
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Immuron Limited - Warrants (12/05/2022) (IMRNW) currently reports a PEG ratio of -5.29. That is below the Healthcare sector average of 2.56. Use the charts on this page to explore Immuron Limited - Warrants (12/05/2022)'s PEG ratio history and peer comparisons.
Immuron Limited - Warrants (12/05/2022)'s PEG ratio of -5.29 is lower than the Healthcare sector average of 2.56. That is roughly 306.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Immuron Limited - Warrants (12/05/2022)'s market price to a fundamental measure such as earnings, sales, or book value. At -5.29, IMRNW can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -5.29, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.56. From there, open related valuation or income-statement pages for Immuron Limited - Warrants (12/05/2022), and consider following IMRNW for alerts when major investors trade the stock.
Immuron Limited - Warrants (12/05/2022) is classified in the Healthcare sector. On PEG ratio, it currently shows -5.29 versus a sector average near 2.56. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMRNW with unrelated industries.